Drug
Ubenimex clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Eiger BioPharmaceuticals (3)
Related medicines
As reviewed, each with the page that says it.
- One of Immunologic Factors source
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses ubenimex is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)CompletedPhase 2Eiger BioPharmaceuticalsNCT02664558Written as ubenimex
- Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)CompletedPhase 2Eiger BioPharmaceuticalsNCT02700529Written as ubenimex
- Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)TerminatedPhase 2Eiger BioPharmaceuticalsNCT02736149Written as ubenimex
Codes
What other systems call ubenimex · ClinicalTrials.gg INT002548
- MeSH (NLM) C012211ubenimexConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) I0J33N5627UBENIMEXConfirmed FDA, NLM, Wikidata
- Wikidata Q10909912ubenimexConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1015UbenimexOne source FDA
- DrugBank DB03424One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C012211 | ubenimex | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | I0J33N5627 | UBENIMEX | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q10909912 | ubenimex | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1015 | Ubenimex | One source FDA |
| DrugBank | DB03424 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.